Awareness, Care & Treatment In Obesity Management - An International Observation (ACTION-IO)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03584191 |
Recruitment Status :
Completed
First Posted : July 12, 2018
Last Update Posted : May 24, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Obesity | Other: No treatment given |
Study Type : | Observational |
Actual Enrollment : | 17287 participants |
Observational Model: | Ecologic or Community |
Time Perspective: | Cross-Sectional |
Official Title: | Awareness, Care & Treatment In Obesity Management - An International Observation (ACTION-IO) |
Actual Study Start Date : | June 4, 2018 |
Actual Primary Completion Date : | October 10, 2018 |
Actual Study Completion Date : | October 10, 2018 |
Group/Cohort | Intervention/treatment |
---|---|
People with Obesity
General population - potential participants will be recruited using various and numerous general population as appropriate in each country.
|
Other: No treatment given
Completion of a survey |
Health Care Professionals
Health Care Professionals include primary care physicians and specialists who treat patients with obesity.
|
Other: No treatment given
Completion of a survey |
- Weight loss motivators [ Time Frame: Start of interviews day 1 until end of data collection day 90 ]Online questionnaire - Multiple Item Selection
- Proportion of PwO / patients who made serious weight loss effort [ Time Frame: Start of interviews day 1 until end of data collection day 90 ]Online questionnaire - Numeric Response
- Response to weight loss discussions [ Time Frame: Start of interviews day 1 until end of data collection day 90 ]Online questionnaire - Single Item Selection
- Effective weight loss methods [ Time Frame: Start of interviews day 1 until end of data collection day 90 ]Online questionnaire - Multiple Item Selection
- Obesity attitudes [ Time Frame: Start of interviews day 1 until end of data collection day 90 ]Online questionnaire - End-anchored 5-point Likert agreement scale (from "1", do not agree at all, to "5" completely agree)
- Attitudes toward prescription weight loss medication and surgery [ Time Frame: Start of interviews day 1 until end of data collection day 90 ]Online questionnaire - End-anchored 5-point Likert agreement scale (from "1", do not agree at all, to "5" completely agree)
- Weight loss barriers [ Time Frame: Start of interviews day 1 until end of data collection day 90 ]Online questionnaire - End-anchored 5-point Likert agreement scale(from "1", do not agree at all, to "5" completely agree)
- Obesity and weight management [ Time Frame: Start of interviews day 1 until end of data collection day 90 ]Online questionnaire - End-anchored 5-point Likert agreement scale(from "1", do not agree at all, to "5" completely agree)
- Degree to which healthcare and society is meeting needs of people with obesity [ Time Frame: Start of interviews day 1 until end of data collection day 90 ]Online questionnaire - End-anchored 5-point Likert needs scale(from "1", do not agree at all, to "5" completely agree)
- Top factors for improving weight loss outcomes [ Time Frame: Start of interviews day 1 until end of data collection day 90 ]Online questionnaire - Ranking Exercise
- Types of weight management goals [ Time Frame: Start of interviews day 1 until end of data collection day 90 ]Online questionnaire - Multiple Item Selection
- Most helpful information for patients for weight loss [ Time Frame: Start of interviews day 1 until end of data collection day 90 ]Online questionnaire - Multiple Item Selection
- Responsibility for improving health of people with obesity [ Time Frame: Start of interviews day 1 until end of data collection day 90 ]Online questionnaire - Multiple Item Selection
- Most helpful support for weight loss [ Time Frame: Start of interviews day 1 until end of data collection day 90 ]Online questionnaire - Multiple Item Selection
- Effectiveness of guidelines for treating obesity [ Time Frame: Start of interviews day 1 until end of data collection day 90 ]Online questionnaire - Fully-anchored 5-point Likert scale (from "1", do not agree at all, to "5" completely agree)
- Ways you receive information on weight loss management [ Time Frame: Start of interviews day 1 until end of data collection day 90 ]Online questionnaire - Multiple Item Selection

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03584191
Australia, New South Wales | |
Novo Nordisk Investigational Site | |
Baulkham Hills, New South Wales, Australia, 2153 | |
Israel | |
Novo Nordisk Investigational Site | |
Kfar Saba, Israel, 44425 | |
Korea, Republic of | |
Novo Nordisk Investigational Site | |
Seoul, Korea, Republic of | |
Mexico | |
Novo Nordisk Investigational Site | |
Polanco, Mexico | |
Saudi Arabia | |
Novo Nordisk Investigational Site | |
Riyadh, Saudi Arabia, 3542 | |
Spain | |
Novo Nordisk Investigational Site | |
Madrid, Spain, 28033 | |
Switzerland | |
Novo Nordisk Investigational Site | |
Zürich, Switzerland | |
United Arab Emirates | |
Novo Nordisk Investigational Site | |
Dubai, United Arab Emirates | |
United Kingdom | |
Novo Nordisk Investigational Site | |
Gatwick, United Kingdom |
Study Director: | Clinical Reporting Anchor and Disclosure (1452) | Novo Nordisk A/S |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Novo Nordisk A/S |
ClinicalTrials.gov Identifier: | NCT03584191 |
Other Study ID Numbers: |
NN8022-4449 U1111-1209-6406 ( Other Identifier: World Health Organization (WHO) ) |
First Posted: | July 12, 2018 Key Record Dates |
Last Update Posted: | May 24, 2019 |
Last Verified: | May 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | According to the Novo Nordisk disclosure commitment on novonordisk-trials.com |
URL: | http://novonordisk-trials.com |
Studies a U.S. FDA-regulated Device Product: | No |
Obesity Overnutrition Nutrition Disorders Overweight Body Weight |